← Back to Search

Behavioral Intervention

Supportive-Expressive Peer Social Support Group + Individual Strengths-Based Case Management for HIV/AIDS

N/A
Recruiting
Led By Jennifer Walsh, PhD
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 50 years or greater
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4, 8, and 12 month follow-ups
Awards & highlights

Study Summary

This trial aims to test two interventions, peer social support groups and case management, to see if they can help improve health outcomes and quality of life for older people living with HIV in rural areas of the

Who is the study for?
This trial is for older adults living with HIV in rural areas of the Southern U.S. who may struggle with accessing care and adhering to their medication regimen. The study aims to help them overcome barriers they face due to aging, location, and medical needs.Check my eligibility
What is being tested?
The study is testing two remote interventions: a supportive-expressive peer social support group and strengths-based case management. It will evaluate how these approaches affect viral suppression, medication adherence, quality of life, and depressive symptoms among participants.See study design
What are the potential side effects?
Since the interventions involve social support and case management rather than medications or medical procedures, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4, 8, and 12 month follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4, 8, and 12 month follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antiretroviral Treatment Medication Adherence
Depressive Symptoms
Health-Related Quality of Life
+1 more
Secondary outcome measures
Accessing Needed Social and Medical Services
General Self-Efficacy
HIV Treatment Adherence Self-Efficacy
+4 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Supportive-Expressive Peer Social Support Group + Individual Strengths-Based Case ManagementExperimental Treatment2 Interventions
Group II: Supportive-Expressive Peer Social Support GroupExperimental Treatment1 Intervention
Group III: Individual Strengths-Based Case ManagementExperimental Treatment1 Intervention
Group IV: HIV Information OnlyActive Control1 Intervention
This arm will not receive either of the interventions but will receive information on successfully aging with HIV.

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
580 Previous Clinical Trials
10,376,209 Total Patients Enrolled
Medical College of WisconsinLead Sponsor
610 Previous Clinical Trials
1,162,361 Total Patients Enrolled
Jennifer Walsh, PhDPrincipal InvestigatorCenter for AIDS Intervention Research, Medical College of Wisconsin
1 Previous Clinical Trials
61 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings for participants in this ongoing trial?

"As per information from clinicaltrials.gov, the ongoing trial is not actively seeking participants. Initially uploaded on March 1st, 2024, and last revised on February 13th, 2024. Despite this particular trial being inactive for recruitment presently, there are a significant number of other trials - precisely 237 - that are currently enrolling subjects."

Answered by AI

What are the main goals and purposes of this investigation?

"The aim of this investigation, with follow-up assessments at around 4 and 12 months post-enrollment, is to evaluate adherence to Antiretroviral Treatment (ART) Medication. Ancillary measures encompass Social Support assessed via the 19-item Medical Outcomes Study (MOS) Social Support Scale by Sherbourne & Stewart in 1991 where scores from 1-5 denote varying levels of support; General Self-Efficacy evaluated through the New General Self-Efficacy Scale comprising eight items developed by Chen et al., in 2001 where higher scores indicate increased self-efficacy; and Loneliness gauged"

Answered by AI
~235 spots leftby Jan 2027